doubled the fractional transfer of recycled retinol from slowly turning-over pools of vitamin A to plasma. The residence time for vitamin A was reduced by 70% in TCDD-treated rats, transfer into urine and feces was tripled, and vitamin A utilization rates were significantly increased. Since our results do not indicate that retinol esterification is inhibited, we hypothesize that some of the significant effects of TCDD on vitamin A metabolism result from increased catabolism and mobilization of vitamin A from slowly turning-over pools (especially the liver), o IWS society of Tmdcoi ogy.
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Vitamin A 4 is an essential nutrient that is required for normal vision, growth, reproduction, cell differentiation, embryonic development, and immune function in mammals (see review by Underwood, 1984) . Much is known about the complex transport and metabolism of vitamin A (see review by Blaner and Olson, 1994) . Recent research has established that retinoids are a key regulator of gene expression, exerting their biological effects by interaction with nuclear receptors (see review by Mangelsdorf et al., 1994) .
Various studies have demonstrated that the normal metabolism of vitamin A is affected by alterations in vitamin A status, physiological state, or exogenous variables. One exogenous factor that has profound effects on vitamin A metabolism in many species is exposure to the persistent environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (see review by Zile, 1992) . This widespread, highly toxic dioxin causes general body wasting, impaired growth and reproduction, compromised immune function, epidermal effects, and hepatotoxicity (see review by Pohjanvirta and Tuomisto, 1994) . It is known that binding of TCDD to the nuclear aryl hydrocarbon (Ah) receptor affects gene transcription. In the rat, TCDD exposure causes a decrease in liver vitamin A levels, an increase in kidney vitamin A, and often an increase in plasma retinol levels (Hakansson and Ahlborg, 1985; Bank et al., 1989; Hakansson et al, 1991a, b; van Birgelen et al., 1995) .
TCDD also inhibits the normal storage of newly ingested vitamin A in liver (Hakansson and Ahlborg, 1985) , most notably in perisinusoidal stellate cells (Hakansson and Hanberg, 1989) , and it increases the mobilization of endogenous retinoids from liver (Hakansson et al., 1988) . In addition, TCDD exposure increases excretion of vitamin A metabolites in urine and feces (Hakansson and Ahlborg, 1985; Hakansson et al., 1988) , increases the glucuronidation of retinoic acid in vitro (Bank et al., 1989) , and results in increased retinoic acid catabolism in microsomes from various tissues (Fiorella et al., 1995) . At least some of the effects of TCDD on vitamin A homeostasis seem to be the consequence of changes in gene transcription and thus enzyme production (Zile, 1992; Pohjanvirta and Tuomisto, 1994) . Furthermore, Weston et al. (1995) reported that the retinoic acid-dependent induction of genes for cellular retinoic acid-binding protein II and retinoic acid receptor-/3 are inhibited by TCDD.
Here we investigated the mechanisms involved in the effects of TCDD exposure on vitamin A metabolism by using modelbased compartmental analysis to determine which whole-body vitamin A kinetic processes are perturbed by TCDD treatment in the rat. Although model-based compartmental analysis has not been as widely used in toxicology and pharmacology as other approaches [e.g., physiologically based pharmacokinetic modeling (PB-PK; Andersen, 1995) ], it has been fruitfully applied to data on the metabolism of vitamin A and other nutrients, metabolic fuels, hormones, and organ systems (see references in Green and Green, 1990a ). Here we collected data on vitamin A kinetics in plasma, tissues, and excreta of control rats and those exposed to weekly doses of TCDD after administration of a radioactive (tracer) dose of vitamin A. We hypothesized that TCDD might disrupt vitamin A homeostasis by affecting vitamin A utilization and recycling of retinol among plasma, liver, and extrahepatic tissues or by altering the uptake and processing of newly absorbed retinyl esters. To examine the first hypothesis, [ 3 H]retinol tracer was administered in its normal vitamin A plasma transport complex (experiment 1) so that effects of TCDD on utilization and recycling could be determined; to address the second hypothesis, [ 3 H]retinyl ester-labeled lymph chylomicrons were administered (experiment 2) to trace the metabolism of newly ingested vitamin A. Then we applied model-based compartmental analysis (Foster and Boston, 1983; Green and Green, 1990a) to tracer data in order to quantify effects of TCDD exposure on the kinetic behavior of vitamin A. Our results suggest that previously observed effects of TCDD on vitamin A metabolism are not related to decreases in plasma vitamin A transport to rapidly and slowly turning-over extravascular vitamin A pools, nor to defects in esterification of vitamin A, but rather to increased turnover of storage pools, resulting in net mobilization of stored vitamin A, and to increases in irreversible utilization of vitamin A.
MATERIALS AND METHODS

Animals and Diets
Studies were carried out at the Karolinska Institute, Stockholm, Sweden; animal experiments were approved by the Institute's Animal Care and Use Committee. All procedures were done under light filtered through transparent films of titanium 35 (TESAB Solna AB, Solna, Sweden) to prevent photooxidation of vitamin A.
Weanling male Sprague-Dawley rats (B&K Universal, Sollentuna, Sweden) to be used as recipients of radioactive vitamin A were housed in shoebox cages in an environmentally controlled animal facility which had a 12-h light cycle (lights on 0700-1900 h). Tap water and a commercial diet (catalogue No. R34; Lactamin, Stockholm, Sweden) were provided continuously. Assuming average daily food intakes of 15-20 g/day, rats consumed 63 to 84 nmol vitamin A/day. This amount was chosen so that control rats would be in a slight positive vitamin A balance.
TCDD Dosing Protocol
TCDD (Lot 851:144-11) was a generous gift from Dow Chemicals (Stockholm, Sweden). A stock solution containing 100 fig TCDD/ml toluene was stored in darkness. Two working solutions of TCDD in corn oil were prepared; one, used for initial loading doses, contained 3.5 jig TCDD/ml and the second, used for subsequent weekly maintenance doses, contained 0.7 jig TCDD/ml. As discussed by FlodstrOm et al. (1991) , this dosing protocol was designed to produce a quasi steady state with respect to TCDD, but was not lethal and would presumably be effective in altering plasma and liver vitamin A levels.
After rats had been maintained on the experimental diet for 7 weeks (experiment 1) or 6 weeks (experiment 2), they were assigned by body weight to one of two groups. The loading dose (3.5 /xg TCDD/kg body weight in 1 ml corn oil/kg; TCDD group) or an equal amount of corn oil (control group) was administered intragastrically. Rats to be used in long-term kinetic studies (see below) were put into metabolic cages (Techniplast Model 1700; Scanbur, Koge, Denmark); rats in short-term studies in experiment 2 were returned to shoebox cages. Maintenance doses of TCDD (0.7 fig, TCDD/kg body weight in 1 ml corn oiiykg; TCDD group) or equal amounts of corn oil (control group) were given 7 days after the initial loading dose and weekly thereafter. (Green and Green, 1990b) . Briefly, weanling male Sprague-Dawley rats (B&K Universal; n = 2) were fed a vitamin A-free diet for 7 weeks to deplete hepatic vitamin A stores. Then, [ll,12(N>[ 3 H] retinol (sp act = 1.4 TBq/mmol; NEN, Boston, MA; 18.5 MBq/donor) in an aqueous suspension with Tween 40 (Sigma Chemical Co., St. Louis, MO) was injected iv into these donor rats. After 100 min, blood was taken from the abdominal aorta into heparinized syringes. Plasma presumably containing [ 3 H]retinol/RBP/TTR (Green et al., 1985) was stored under an atmosphere of nitrogen at 4°C and used for kinetic studies over the next 2 days. Weighed replicate aliquots of the dose were taken for analysis of radioactivity (see below).
Experiment
Kinetic study. One day before administration of retinol-labeled plasma to recipient rats, three rats in each group were killed and livers were obtained for analysis of vitamin A ("time 0"). Rats were anesthetized with CO 2 and killed by extracting a large blood sample from the right cardiac ventricle. Livers were excised, blotted, weighed, frozen in liquid nitrogen, freeze-dried, and stored under an atmosphere of nitrogen at -16°C for later analysis (see below).
The kinetic study was started 2 days after administration of the first maintenance dose of TCDD. See Green and Green (1990b) for additional details on protocols used in the kinetic study. Seven rats from each experimental group (control and TCDD) were injected intrajugularly with an accurately weighed amount (-0.4 g containing ~ 180 kBq) of [ 3 H]retinol-labeled plasma. Over the next 42 days, serial blood samples (n = 29; 0.1-0.25 ml) were taken from a caudal vein into microcentrifuge tubes containing 25 IU heparin; sampling times were chosen based on a geometric progression. Plasma aliquots were frozen in minivials under nitrogen for later analysis of tritium. At selected times throughout the turnover study (8 samples/rat), additional aliquots were taken for analysis of plasma retinol concentration (see below). For each rat, urine and feces were collected as pools during day 1 (0-24 h after administration of isotope), days 1-4 (24-96 h after dosing), days 4-7 (96-168 h), and days 7-10 (168-240 h following isotope administration). At each of these times, the rat was moved to a clean metabolic cage (or, on day 10, to a shoebox cage). Urine that had accumulated in the collection cylinder was transferred into a preweighed disposable vial; the cage was rinsed twice with a total of 5-6 ml ethanol:distilled water (1:1), and rinses were combined with urine. The sample was reweighed and aliquots (3X -1 g) were weighed into minivials and frozen for later analysis of tritium (see below). Feces were transferred from their collection cylinder into sample bags, weighed, frozen, lyophilized, and stored at -16°C for later analysis of radioactivity (see below).
Forty-two days after administration of labeled plasma, rats were killed as described above. In addition to removing livers, the thymus glands were excised and weighed (so that effects of TCDD on thymus weight could be determined) and then returned to the carcass. Carcasses were weighed and frozen at -16°C until analyzed for radioactivity (see below).
Experiment 2 Preparation of[
3 HJvitamin A-Iabeled lymph chylomicrons. Rats (n = 2) were anesthetized and the main mesenteric lymph duct was cannulated by the procedure of Hanberg and Trossvik (1995) . On the morning after surgery, 66 TBq of [ll,12(N) 3 H]retinol (NEN) and ~1 /xg of unlabeled retinyl acetate was dissolved in com oil (0.5 ml). Labeled oil (0.25 ml/rat) was administered orally. Lymph was collected for 6 h after dosing into tubes containing 10 /il Na 3 EDTA (0.4 M, pH 7.4); it was filtered through sterile gauze and diluted with unlabeled lymph. Replicate aliquots were taken for analysis of total radioactivity and to determine the fraction of the radioactivity associated with retinol versus retinyl esters (see below). Lymph was stored at 4°C under a nitrogen atmosphere and used within 2 days of collection for in vivo studies.
Kinetic study. Procedures were similar to those described for experiment 1. Beginning 2 days after administration of the first TCDD maintenance dose, rats were injected iv with an accurately weighed amount of labeled lymph (~0.25 g containing -120 kBq). Rats were designated as either short-term or long-term recipients. For rats in the long-term group (TCDD, n = 7; control, n = 8), serial blood samples (n = 32) were collected from a caudal vein for 42 days after dose administration. Plasma aliquots were frozen under nitrogen for later analysis of tritium and, at selected times, for retinol concentration (see below). In addition, aliquots of plasma collected during the first 2 h after dosing were frozen for analysis of tritium in retinol versus retinyl esters (see below). Urine and feces were collected as individual animal pools for 4 days after dosing; rats were then returned to shoebox cages. On day 42, long-term recipients were anesthetized and killed.
For short-term recipients in experiment 2 (3 rats/group/time), several blood samples were taken after administration of labeled lymph before rats were killed at 25 min, 8 h, and 2 days. In addition to the procedures done for experiment 1, small intestines and contents were excised, frozen in liquid nitrogen, Iyophili2ed, and refrozen for analysis of tritium (see below). Small intestines were examined separately from the rest of the carcass to verify that our dose was physiological (Green and Green, 1996) and to check whether TCDD caused a rapid metabolism and excretion of the administered label into bile.
Plasma and Tissue Analyses
Plasma samples (40-200 /J) and aliquots of the vitamin A-labeled doses were analyzed for tritium (Model 1409; Wallac Sverige AB, Upplands Vasby, Sweden) after addition of 5 ml of scintillation solution (Ecoscint A; National Diagnostics, Hintze, Stockholm, Sweden). Samples were counted twice to a final 2(r error of 1%. After background correction, net counts/min (cpm) were converted to disintegrations/min (dpm) using an external standard channels ratio method.
The amount of vitamin A in plasma was determined by HPLC in eight of the serial plasma samples collected from each rat in the 42-day studies. Using a modification of the procedure of Thompson el aL (1971) , retinol was extracted from 50% ethanol into hexane containing 23 jtM butylated hydroxytoluene (BHT); retinyl acetate was used as an internal standard. Solvent-free extracts were resuspended in ethanol and chromatographed on a Nucleosil 5 ft C18 Resolve HPLC column (150 X 4.6 mm; Phenomenex, Torrance, CA) using methanol:wateT (90/10 v/v, 1 ml/min) as the mobile phase. Retinol and retinyl acetate peaks were detected by UV absorbance at 328 am (Model 486; Waters Assoc., Milford, MA). The areas under the peaks for retinol and retinyl acetate were obtained by integration (MiniChrome vl.66; Fisons Instr., VG Data Systems, Cheshire, UK) and an internal standard method was used to quantitate the amount of retinol in each sample.
Radioactivity in retinol and retinyl esters was determined in aliquots of the lymph chylomicron dose, and in plasma samples (n = 9) collected during the first 120 min after dose administration for long-term rats in experiment 2. Plasma samples were extracted as above. The hexane extracts were loaded onto columns of neutral aluminum oxide (Aldrich/LabKemi, Stockholm, Sweden) deactivated with 5% water (Ross, 1982) . Retinyl esters were eluted with 3% diethylether in hexane and retinol with 50% diethylether. Fractions were analyzed for tritium (LS 1801; Beckman instruments, Stockholm, Sweden) using Ecoscint O (National Diagnostics) as scintillation solution.
Triplicate aliquots of freeze-dried liver (0.15 g) were saponified in ethanolic KOH and lipids were extracted into hexane containing 23 /xM BHT (Green et al., 1985) . A portion of the extract was analyzed for tritium as described for plasma, using Ecoscint O as scintillation solution. Other aliquots were analyzed for vitamin A content by HPLC as described above.
Additionally, radioactivity in liver retinol and retinyl esters was determined for short-term animals in experiment 2. Retinoids were extracted using the hexane:isopropanol:sodium sulfate method of Hara and Radin (1978) as described by Adams et al. (1995) . Radioactivity in extracted retinol and retinyl esters was determined by column chromatography and liquid scintillation spectrometry as described above for plasma.
The tritium content of urine was measured (Model 1215 Rackbeta II; LKB/Wallac, Uppsala, Sweden) after addition of Ecoscint A to triplicate aliquots of urine. Conversion of net cpm to dpm for each sample was done using an external standard channels ratio method.
Fecal radioactivity was determined using a modification of the method of Hakansson and Ahlborg (1985) . Briefly, freeze-dried feces were ground in a mortar. Quadruplicate aliquots (0.07-0.1 g) were incubated for 2 h in 4 ml methanol while mixing (200 rpm) at 56°C. After incubation, samples were vigorously vortexed for 15 min and then centrifuged for 6 min at 3000 rpm. The methanol was aspirated into glass scintillation vials and the extraction was repeated twice, using 2 ml methanol each time and 15-min incubations. After solvent had evaporated, extracts were analyzed for radioactivity using Ecoscint O as the scintillation solution.
Tritium in carcasses was determined using the method of Adams et aL (1995) . Carcasses were coarsely ground using a meat grinder and five aliquots (-1.5 g each) were extracted using hexane:isopropanol:sodium sulfate. Solvent was evaporated and extracts were analyzed for radioactivity using Ecoscint O as the scintillation solution. Freeze-dried small intestines from short-term rats in experiment 2 were similarly extracted and counted.
Kinetic Analysis
Model-based compartmental analysis (Foster and Boston, 1983; Green and Green, 1990b ) was used to develop the simplest model that fit tracer data for experiment 1. As described by Green and Green (1990b) , the fraction of the dose of injected radioactivity (fdose) remaining in plasma at each sampling time for each rat was calculated as dpm/ml of plasma divided by dpm injected/estimated plasma volume, where plasma volume was approximated as mean body weight (g) during the 42-day kinetic study X 0.038 ml plasma/g body weight. For each rat, the fraction of the injected dose of radioactivity in liver, carcass, urine, and feces was calculated as tissue dpm divided by the total dpm injected. The fraction of the dose that was irreversibly lost by the end of each rat's study was calculated as 1 -(fdose liver + fdose plasma + fdose carcass) for experiment 1 and as 1 -(fdose liver + fdose plasma + fdose carcass + fdose small intestine) for experiment 2.
Individual animal data on plasma fdose versus time were fit to a multiexponential equation using CONS AM the conversational version 31 (Berman etal, 1983) , the conversational form of the Simulation, Analysis and Modeling computer program (SAAM; Berman and Weiss, 1978) . Programs were run on an IBM 80486 microcomputer. For each rat, the sum of the intercepts was used to adjust the initial estimate of plasma volume that had been calculated from body weight at the time of dose administration. Then we used CONSAM to compare normalized data for plasma, urine, feces, and irreversible loss for each rat to die threecompartment model for vitamin A metabolism proposed by Green and Green (1994) . We found that a four-compartment model provided the best fit to tracer data from experiment 1 (see Results). Weighted, nonlinear regression analysis was done using CONSAM in order to determine values for the model parameters (fractional transfer coefficients [LflJ)s] or the fraction of compartment J's tracer transferred to compartment I each day) for each rat. For weighting purposes, a fractional standard deviation of 0.05 was assigned to each datum for plasma and irreversible loss, while a fractional standard deviation of 0.1 was given to urine and feces data, to reflect the potentially larger error in collection and analysis of excreta. Goodness-of-fit of the proposed model was determined by visual inspection of model-predicted versus observed data and by calculation of the estimated fractional standard deviation for each L(IJ). Parameters were considered well identified if their estimated variability was less than 0.5 (Jacquez, 1996) . Next, the multiple studies feature of SAAM (Lyne et at, 1992) was used to calculate average fractional transfer coefficients for each group and the population estimate of the standard deviation.
Data from experiment 2 were handled similarly, using the final model from experiment 1 as a starting point and after addition of compartments related to chylomicron metabolism, except that estimates of plasma volume were not adjusted because of the rapid and variable removal of chylomicrons, data for urine and feces were not weighted since only one collection was made (a 4-day pool after isotope administration), and early data for fraction of dose in plasma retinyl esters and retinol were given fractional standard deviations of 0.05. A seven-compartment model with a delay element was needed to fit these data. Differences between the models presented for the two studies reflect not only the complexity needed to account for metabolism of vitamin A in chylomicrons in experiment 2, but also a difference in the number of slowly turningover extravascular compartments needed to fit the data (one in experiment 2 versus two in experiment 1).
Using the model-predicted fractional transfer coefficients, several additional kinetic parameters were calculated for each experiment; see Green and Green (1990b) for more information on these calculations. Transit time [f(I)] is the length of time an average molecule of tracer spends in compartment I during a single transit It was calculated as 1/2L(J,I). T(IJ), or mean residence time, is the total time an average retinol molecule spends in compartment I before irreversible exit from compartment I after entering the system via compartment J; it is equal to the area under the tracer response curve integrated from 0 to infinity [AUC(I r T)]. Plasma fractional catabolic rate [FCRp] , or the fraction of the plasma rctinol pool that is irreversibly utilized each day, was calculated as in~(I). The number of times that a retinol molecule recycles through compartment I before irreversible loss is the recycling number [i<I)]. It was calculated as [T(I)/r(I)] -1. T(SYS), or system mean residence time, expressed by the equation T(SYS) = Sf (IJ), is defined as the total time a vitamin A molecule spends in the system before irreversible loss. The time that it takes for the average molecule which leaves compartment I to cycle back to compartment I is known as the recycling time [ff(T)]; it was calculated as [T(SYS) -f (I)]/u(r). Finally, to calculate the system disposal rate for vitamin A (DR), individual animal mean plasma retinol pool sizes (mean plasma retinol concentration measured during the kinetic study * estimated plasma volume) were multiplied byFCR,,.
Statistical Analysis
Data are presented as arithmetic group mean ± 1 standard deviation. For descriptive data and kinetic parameters calculated from the model L(U)s, a standardized t test with an alpha level of 0.05 was used (Ryan et at, 1985) to test for significant differences between groups. For group population mean L(IJ)s in each experiment, a t test (SigmaStat) was used to test for significant differences between groups.
RESULTS
Descriptive Data
Body weights at the time of administration of vitamin A-labeled doses averaged 426 ± 34 g for rats in experiment 1 and 413 ± 35 g for those in experiment 2. Body weight gain was significantly lower for TCDD-treated versus control rats in experiment 2, and it tended to be lower in experiment 1 ( Table  1) . As shown in Table 1 , liver weights were not significantly affected by TCDD, but relative liver weights were significantly higher in TCDD-treated rats. Thymus weights and relative thymus weights were significantly lower in TCDD-treated versus control animals in experiment 1 and tended to be lower in experiment 2.
In addition, TCDD treatment was associated with changes in vitamin A levels in plasma and liver (Table 1) . Plasma retinol concentrations were higher in TCDD-treated rats, although the difference was not significant in experiment 2 (p < 0.066). Liver vitamin A levels were reduced by 60% (experiment 1) and 44% (experiment 2) in TCDD-treated versus control rats 8 days after administration of the TCDD loading dose (t 0 ). Differences were even greater (97 and 95%) 42 days later (t,). As indicated in Table 1 , we estimate that control rats in both experiments were in a positive vitamin A balance, whereas TCDD-treated rats were in negative balance.
Experiment 1: Kinetic Data
In order to determine which aspects of whole-body vitamin A kinetics were affected by TCDD exposure, we administered [ Note. Data are means ± SD. In experiment 1, n = 7 for both controls and TCDD-treated; in experiment 2, n = 8 for controls and n = 7 for TCDD. For t 0 liver vitamin A, n = 3. BWt, body weight; [R0H] p , plasma retinol concentration; tg, time zero (1 day before tracer administration and 8 days after the TCDD loading dose); (" end of kinetic study (42 days after tracer administration).
" Body weight gain was calculated over the 42-day kinetic study. * Values are mean plasma retinol concentration during the 42-day kinetic study based on eight measurements/rat There were no significant effects of time on plasma rctinol concentrations.
c Liver vitamin A balance was estimated as (/, liver vitamin A -t 0 liver vitamin A)/43 days.
* Significantly different (p < 0.05) from controls in the same experiment.
between plasma and slowly turning-over extravascular pools of vitamin A; the shape and timing of the bend is related to liver vitamin A levels (Green et al., 1987) . After 10-14 days, the curve reached a constant, terminal slope. For TCDD-treated rats (Fig. 1, dotted line) , the same general features in plasma tracer response curves were apparent but responses for the two groups diverged as early as 21 min after administration of the labeled dose. The earlier bend indicates a more rapid recycling of labeled retinol to plasma from rapidly turning-over extravascular pools of vitamin A in TCDD-treated rats. The steeper terminal slope indicates a higher fractional rate of loss of labeled vitamin A from the system in TCDD-treated rats compared to controls. At 42 days after dose administration, TCDD treatment was associated with a dramatic reduction in recovery of the label in liver (1.6% versus 30% in control rats), whereas the fraction of the dose in carcass was not affected by TCDD treatment (Table  2 ). In both control and TCDD-treated rats, substantially more radioactivity was recovered in methanol-soluble extracts of feces than urine (Table 2) . Cumulative excretion of radioactivity in urine and feces was higher in TCDD-treated versus control rats so that, at 10 days, cumulative urinary recovery was 100% higher in TCDD-treated rats and that in feces was 28% higher.
Experiment 1: Model Development and Kinetic Parameters
In view of some similarities in experimental design, liver vitamin A levels, and the geometry of the plasma tracer response profiles, we began model development using the threecompartment model proposed by Green and Green (1994) . In that model, dietary vitamin A enters the system via a central plasma compartment; this is also the site of introduction of tracer. Plasma retinol in compartment 1 could then exchange with vitamin A in both a small, rapidly turning-over extravascular pool and a larger, slowly turning-over extravascular pool before leaving the system from the more slowly turning-over pool. The rapidly turning-over pool was postulated to represent a pool of intracellular retinol and retinol in interstitial fluid and possibly vitamin A filtered by the kidney which is in the process of being reabsorbed. The more slowly turning-over compartment would include vitamin A in retinyl ester-containing storage pools, primarily in the liver.
Plasma tracer data for individual rats in experiment 1 were compared to the three-compartment starting model. Even with the addition of separate outputs to accommodate data for urine and feces, that model did not adequately fit the current data for plasma tracer between days 2 and 10. Specifically, simulations of the three-compartment model predicted a much lower recycling of the label into plasma from the slowly turning-over pool than was observed here. Thus, we added a fourth compartment exchanging with the more slowly turning-over extravascular compartment (Fig. 2) , hypothesizing that this compartment includes the least dynamic pools of body vitamin A (e.g., retinyl esters in lipid droplets of hepatic perisinusoidal stellate cells and in other large, slowly turning-over extrahepatic vitamin A stores). Addition of a fourth compartment resulted in a significant improvement in the sum of squares as determined by an F statistic (Landaw and DiStefano, 1984) ; thus, this structure was accepted as our working model.
Values for the model parameters [i.e., the fractional transfer plasma from this pool [L(l,2)] was slightly but not significantly higher in the same group. The most dramatic effects of TCDD were seen on the more slowly turning-over vitamin A compartments (compartments 3 and 4): fractional release of
coefficients or L(I,J)s] for each rat were adjusted to obtain the best fit of the data to the proposed model. The model's ability to fit the data is indicated by comparing the model-predicted values for plasma tracer response versus time (solid and dotted lines; Fig. 1 ) to the observed values (symbols). A good match was also obtained between observed and predicted data for irreversible loss on day 42 (Fig. 1 ) and for tracer excretion in urine and feces (data not shown). All model parameters were well identified, based on the criterion that the estimated fractional standard deviations for each L(IJ) in each rat's model was less than 0.5 and in most cases, they were less than 0.15. Using the multiple studies feature of CONSAM (see Materials and Mediods), group mean fractional transfer coefficients [L(I J)s] and their statistical uncertainties were calculated (Table 3). L(2,l), the fractional transfer of retinol from plasma to the rapidly turning-over extravascular compartment, was significantly higher (43%) in TCDD-treated rats; die transfer to 
WA)
U31 . • Significantly different from controls (p < 0.05).
label from compartment 3 to plasma [L(l,3)] was doubled with TCDD treatment, but there was no influence on uptake from the plasma [L(3,l)]. L{4,3) and L(3,4) were each 2.6 times higher in TCDD-treated than in control rats, indicating a greatly increased turnover of vitamin A between these pools. Using model-predicted L(I,J)s for each rat, additional kinetic parameters (Table 4) were calculated as described under Materials and Methods. Although TCDD exposure did not significantly affect the transit or residence times for retinol in compartment 1 (plasma) or in the rapidly turning-over extravascular compartment (compartment 2), TCDD caused a reduction in the mean transit time for vitamin A in compartments 3 and 4 [7(3) and 7(4)] by 60 and 68%, respectively, compared to controls. Mean residence times in compartments 3 and 4 [f(3) and f(4)] were reduced by 65 and 73%, respectively, with TCDD treatment, so that the time that the average vitamin A molecule spent in the entire system before leaving irreversibly [f(SYS)] was reduced by 70% in TCDD-treated rats. After TCDD exposure, the average vitamin A molecule took one-third the time to recycle to plasma [H(l)] of the time in controls, and it recycled about three more times before being irreversibly utilized [u(l)]. Although the plasma tracer response curves for TCDD-treated rats showed a steeper terminal slope (Fig. 1) , the plasma fractional catabolic rate (FCRp) was not significantly affected by TCDD (Table 4) . This seeming contradiction is due to the relative contributions of early and later responses to the area under the curve and the increased retinol recycling to plasma in TCDD-treated rats. The vitamin A disposal rate (DR) was significantly higher (27%) in TCDDtreated than control rats.
Experiment 2: Kinetic Data
In order to examine effects of TCDD exposure on the metabolism of dietary vitamin A, rats in experiment 2 were injected with [ 3 H]retinyl ester-labeled lymph chylomicrons. Plasma tracer response curves for a representative control and TCDD-treated rat versus time after administration of labeled chylomicrons are presented in Fig. 3 . Curves for other animals followed similar patterns. The majority (90.5%) of the radioactivity in the administered lymph chylomicron dose was present as retinyl esters (Fig. 3, bottom) . In control animals, essentially all of the injected radioactivity was cleared from the plasma within the first 30 min (Fig. 3, middle, solid Values are group mean model-predicted kinetic parameters ± SD for control (n = 7) and TCDD-treated rats (n = 7). The model is presented in ences between controls and TCDD-treated rats were evident even at very early times after dosing. Specifically, there was an earlier bend in the plasma tracer response curve between 10 and 30 min in the TCDD-treated rat (Fig. 3 , middle, dotted line), a later peak in plasma retinol radioactivity (215-260 min), and wider appearance of die "hump." At later times (Fig.   3, top) , as in experiment 1, plasma response profiles for TCDD-treated rats showed an earlier bend (beginning at ~1 day) and a much steeper terminal slope, compared to controls.
Essentially all of the administered radioactivity (>94%) was recovered in plasma + liver + small intestine + carcass at 25 min in both groups. Recovery of the radioactive dose in small intestines was low in the short-term rats from both groups, averaging 0.4-1% at 25 min and 1.8-2.6% at 8 h. This result indicates that essentially none of the chylomicron dose had been cleared via the liver reticuloendothelial system and excreted into bile and small intestine, as it might have been if the dose had contained a nonphysiological component.
Hepatic recovery of the radioactive dose is shown in Table  5 . At all times, the majority of the radioactivity in liver was in retinyl esters. For control rats, hepatic recovery at 8 h was lower than that at 25 min. At 8 h and 2 days, hepatic recoveries were significantly lower in livers of TCDD-treated versus control rats. By 42 days, differences between the groups were even more marked than in experiment 1, with only 0.6% of the dose recovered in livers of TCDD-treated rats versus 46% in controls.
Recovery of the injected radioactive dose in carcass (Table  5) was similar for TCDD-treated and control rats at 25 min, whereas recovery tended to be higher at 8 h (18%) and it was ]vitamin A-labeled lymph chylomicrons recovered in total liver, liver retinyl esters (RE), carcass, urine, and feces. Urine and feces were collected as one 4-day pool from the time of administration of label. N = 3 for control and TCDDtreated rats killed at 25 min, 8 h, and 2 days after administration of label, n = 8 for controls killed at 42 days, and n = 7 for TCDD-treated rats at 42 days.
* Significantly different from controls (p < 0.05).
significantly higher (66%) at 2 days in TCDD-treated than in control rats. By the end of the experiment, recovery of the labeled dose in carcass had decreased to levels lower than those observed in experiment 1 and was significantly lower in TCDD-treated rats than in controls. As in experiment 1, TCDD treatment was associated with significant increases in urinary and fecal excretion of labeled vitamin A, and more of the dose radioactivity was excreted in feces than in urine (Table 5) . At 4 days after administration of the labeled dose, cumulative recovery of radioactivity was almost three times higher in urine and feces of TCDD-treated versus control rats. Although >94% of the administered radioactivity was recovered at 25 min, at later times, the recovery was lower due to metabolism and excretion of the label. For example, recovery in plasma + liver + carcass + small intestine at 2 days averaged 80.7 ± 1.6% (n = 3) in control rats and 51.7 ± 3.6% (n = 2) in TCDD-treated animals. Assuming that excretion of radioactivity in urine and feces at 2 days was less than that observed at 4 days, some of the dose (~15% in controls and 20% in TCDD-treated rats) had already been converted to nonextractable polar metabolites. The nonrecovery of such polar metabolites would not alter our kinetic analyses or results, since, once retinol is metabolized to retinoic acid or other polar metabolites, it cannot recycle to plasma retinol and is thus irreversibly utilized from the kinetic perspective. Still, additional useful information could be obtained in future studies by using a biological materials oxidizer to combust samples of carcass and feces to 3 H 2 O prior to liquid scintillation spectrometry.
Experiment 2: Model Development and Kinetic Parameters
We began model development for experiment 2 data using the four-compartment model developed in experiment 1, after addition of compartments needed to account for the introduction of the label on lymph chylomicrons (Fig. 4) . In view of the distribution of label in lymph, 90.5% of the dietary input into the system [U(I)] is shown into the plasma retinyl ester input compartment (compartment 5) and 9.5% into a chylomicron retinol compartment (compartment 11). In order to explain the complex geometry of the initial portion of the curves and based on current understanding of the metabolism of vitamin A in chylomicrons, a fraction of labeled chylomicron retinyl esters was transferred from compartment 5 to a rapidly turning-over extravascular compartment (compartment 7) that was needed to fit early data for [
3 H]retinyl esters in plasma. To fit the later rise in labeled plasma retinol, a delay element (component 6), presumably in the liver, was also required. The model requires that, after processing through compartment 7 and component 6 (which together probably represent liver uptake of chylomicron-derived retinyl esters, hydrolysis of the esters, and transfer of retinol to apoRBP), labeled retinol is released into plasma (compartment 1) bound to RBP. Labeled retinol in the administered dose (compartment 11) was processed through a Compartments 5, 7, 9, and 11, and delay component 6, were used to fit data for plasma tracer disappearance and hepatic processing of chylomicron vitamin A; compartment 1 represents plasma retinol; compartments 2 and 3 are extravascular pools of vitamin A. The asterisks indicate sites of tracer introduction (90.5% into compartment 5 as retinyl esters and 9.5% into compartment 11 as retinol) and U(5) represents dietary input into the system. As an example, the differential equation used to describe the change in labeled vitamin A present in compartment 1 is dQ,/dt = L(1,6)*Q(6) + L(1,2)*Q<2) + U1,3)*Q(3) + L(1,9)*Q<9) -[{L<3,1)*Q(1)) + (L(2,1)*Q(1)}], where Q| equals the amount of labeled vitamin A in compartment I and L(IJ)s are fractional transfer coefficients. single extravascular compartment (compartment 9) before transfer into plasma compartment 1. As in the model developed for experiment 1, once the label was secreted into plasma, it was able to exchange with vitamin A in both a rapidly turningover extravascular compartment (compartment 2) and a more slowly turning-over extravascular compartment (compartment 3) before leaving the system irreversibly through compartment 3. Since less extensive information on urinary and fecal output of radioactivity was collected in the second experiment, the model shows only one site of output [L(0,3) ]. Also, in contrast to the model developed for experiment 1, a second slowly turning-over extravascular compartment was not statistically justified.
As in experiment 1, tracer data for each rat were fit to this model by adjusting the values for the fractional transfer coefficients [L(IJ)s]. As is evident in Fig. 3 by comparing observed 
U\J)
Control TCDD L(7,5) (days" 1 ) U5,7) (days" 1 ) L(6,7) (days" 1 )
185 ±48 1.82 ±0.72 6.10 ± 0.84 37.3 ± 3.4 222 ± 67 6.10 ± 1.79 12.6 ± 3.8 2.48 ± 1.44 15.4 ± 3.9 0.0931 ± 0.0169 0.0200 ± 0.0042 240 ± 118 13.8 ± 12.2* 10.8 ±5.1* 56.4 ± 11.3* 258 ± 93 6.96 ± 3.73 16.9 ± 8.1 5.86 ± 2.98* 13.6 ± 3. • Significantly different from controls (p < 0.05).
data (symbols) to the model predictions (lines), the model provided a good fit to plasma tracer data. All parameters were well identified (estimated parameter FSDs < 0.5), with the highest variability seen in L(5,7). Group mean fractional transfer coefficients and their statistical uncertainties are shown in Table 6 . Several parameters associated with metabolism of the chylomicron dose [L(5,7), L(6,7), and DT(6)] were significantly higher in TCDD-treated than in control rats. The increase in L(5,7) suggests that a higher fraction of the label that reaches the liver on absorptive lipoproteins is recycled to plasma before hepatic uptake in TCDD-treated rats (56% versus 23% in controls). The increase in L(6,7) in the TCDD group indicates that, after intemalization, label was more rapidly transferred to the delay component. Before secretion into plasma as [ 3 H]retinol bound to RBP, the processing of the labeled diet-derived vitamin A in liver [DT(6)] took 51% longer in TCDD-treated rats. For the parameters related to metabolism of retinol/RBP, fractional transfers of retinol from plasma compartment 1 to extravascular compartments 2 and 3 [L(2,l) and L(3,l), Table 6 ] were unaffected by TCDD treatment but die L(IJ)s reflecting recycling to the plasma compartment from compartments 2 and 3 were both more than doubled in TCDD-treated rats. Finally, the fraction of label that was irreversibly lost from the system [L(0,3)j was 3.6 times higher in animals given TCDD than that in controls.
Additional kinetic parameters for experiment 2 are presented in Table 7 . The mean transit time for vitamin A in compartment 7 [f(7)] was 49% lower after TCDD exposure. Mean transit times in compartment 1 [f(l)] were similar to those determined in experiment 1 and were not different for TCDDtreated versus control rats. TCDD caused significant reductions (57 and 60%) in the transit times in compartments 2 and 3, respectively. The mean residence times [f (I)] in compartments 1-3 were all significantly reduced with TCDD treatment. Of these perturbations, the most dramatic effect was seen in compartment 3, where TCDD caused a 74% reduction in mean residence time. The reduced residence time in compartment 3 was the most significant contributor to the 73% lower system residence time [f (SYS)] in the TCDD-treated rats; this reduction is comparable to that calculated for experiment 1. Vitamin A recycling time [«(!)] was significantly lower (63%) in TCDD-treated rats, whereas the plasma fractional catabolic rate (FCRp) and the disposal rate (DR) were significantly higher (35 and 52%, respectively) in TCDD-treated versus control rats. 
DISCUSSION
As summarized in the introduction and in a review by Zile (1992) , TCDD exposure has a variety of adverse effects on vitamin A metabolism in rats. Here we investigated the mechanisms involved in the effects of TCDD exposure on vitamin A metabolism by using model-based compartmental analysis to determine which whole-body vitamin A kinetic processes are perturbed by TCDD treatment in the rat.
Based on work by HSkansson and Ahlborg (1985) and Hakansson and Hanberg (1989) , which showed that TCDD administration affects the storage and excretion of newly absorbed vitamin A, we speculated that TCDD might disrupt vitamin A homeostasis by altering the uptake and processing of newly absorbed retinyl esters or by affecting the normal, extensive recycling of retinol among plasma, liver, and extrahepatic tissues that has been documented by previous compartmental models (Green et al, 1985 (Green et al, , 1987 . Our results from experiment 2 indicate that there are subtle effects of TCDD treatment on chylomicron clearance, as well as on the rate of processing of chylomicron-derived vitamin A in the liver. However, by 1 day, the model ( Fig. 4) predicts that in both groups, the liver had processed essentially all of the labeled incoming chylomicron vitamin A. Thus, it seems unlikely that the dramatic effects of TCDD on vitamin A metabolism can be attributed to alterations in the metabolism of chylomicrons and/or the initial hepatic handling of chylomicron-derived vitamin A. Additionally, results from both experiments indicate that there is no effect of TCDD on the fractional uptake of RBP-retinol by tissues [L(2,l) and L (3,l) , Tables 3 and 6] .
Although tissue uptake of vitamin A from plasma was unaffected by TCDD treatment, the models predict that TCDD increases the fractional recycling of vitamin A from faster and more slowly turning-over pools into plasma (Table 3) . Liver vitamin A balance data (Table 1) are compatible with the idea that, as liver vitamin A levels decrease (by -90%) during the turnover study in TCDD-treated rats, a larger fraction of the remaining pool is mobilized to maintain a constant rate of retinol secretion into plasma, resulting in stable (although slightly increased) plasma retinol concentrations. Although interesting, this increased mobilization of vitamin A into plasma does not explain how TCDD might be interfering with vitamin A storage in liver (Hakansson and Ahlborg, 1985; Hakansson et al, 1988) and liver stellate cells (Hakansson and Hanberg, 1989; Nilsson et al., 1996) .
Based on a study by Nilsson et al. (1996) , which showed that TCDD decreases both lecithin:retinol acyltransferase and acyl CoA:retinol acyltransferase activity in hepatic stellate cells, we expected to see a lower transfer of label into vitamin A storage pools in experiment 1. However, our kinetic results indicate that vitamin A is moved into storage pools more rapidly with TCDD treatment and that it is also removed more quickly. That is, there may be a futile cycling of vitamin A between compartments 3 and 4, involving increased formation or storage of retinyl esters, and an increased net mobilization of vitamin A (most likely through increased hydrolysis in conjunction with increased degradation). Although Brouwer et al. (1988) found no influence of TCDD on activity of the bile salt-dependent retinyl ester hydrolase (REH) in rat liver homogenates, there is the possibility that the membrane-bound, neutral REH activity, which is present in rat liver stellate cells as well as hepatocytes (Matsuura et al., 1997) , or the acid REH could be involved. In this regard, Nilsson et al. (unpublished data) have found that the activity of membrane-bound, neutral REH activity in whole liver, as well as isolated stellate cells and hepatocytes, is not affected by TCDD treatment. It is worth noting that increased hydrolysis need not require an increase in the amount of REH protein, but might result from an increase in relative activity due to the removal of product.
Regarding effects of TCDD on degradation of vitamin A, our data (Tables 2 and 5 ) and earlier studies (Hakansson and Ahlborg, 1985; Hakansson et al, 1988) show that TCDD treatment results in increased excretion of vitamin A metabolites in urine and feces. Our models predict significant elevations in the irreversible utilization of vitamin A in TCDDtreated versus control rats (Tables 4 and 7 ). The idea (Moore, 1957; Wolf, 1984; Hakansson et al., 1988; Green and Green, 1996) that vitamin A utilization is composed of both a functional (related to the biological activity of vitamin A) and a nonfunctional component (a mechanism for ridding the body of vitamin A through degradation) may be relevant to these observed effects of TCDD exposure. First, it is difficult to imagine a functional process that could account for the magnitude of the depletion in liver vitamin A observed in TCDD-treated rats. Further, work by others (Bank et al., 1989; Fiorella et al., 1995) supports the idea of increases in nonfunctional catabolism, possibly related to TCDD induction of cytochrome P-450 enzymes [see reviews by Zile (1992) and Pohjanvirta and Tuomisto (1994) ]. Such an increase in catabolism might result not only in a decrease in the availability of intracellular retinoic acid for vitamin A action, but also a need for further mobilization from retinyl ester stores.
Due to the significant overlap in the consequences of TCDD toxicity and vitamin A deficiency, it has been suggested (Zile, 1992 ) that some of the toxic symptoms of TCDD exposure may be due to a functional vitamin A deficiency in target tissues. However, the plasma retinol turnover rate for TCDD-treated rats in experiment 1 was ~10 times higher than that predicted for die vitamin A-deficient rats studied by Lewis et al. (1990) . In addition, rats with low vitamin A status had very low vitamin A disposal rates (5.8 nmol/day versus >60 nmol/day in TCDD-treated rats); and residence times for retinol in plasma and liver were much lower than those in TCDD-treated rats. Our results suggest that, at the whole-body level, vitamin A dynamics are dramatically different in TCDD-treated versus vitamin A-deficient rats.
We (Tables 3 and 6 ) and estimated plasma retinol pool sizes (experiment 1 controls, 28.4 nmol, and TCDD, 31.7 nmol; experiment 2 controls, 21.4 nmol, and TCDD, 24.8 nmol) for experiment 1 (top) and experiment 2 (bottom). Inputs, and rates of storage and mobilization, were adjusted to reflect the observed liver vitamin A balances (Table 1) . Estimated rates for TCDD-treated rats are shown in parentheses next to the values for controls.
rates (nmol/day) of vitamin A transfer between compartments and into and out of the system. This was done by adjusting the input rates and the transfer rates related to storage in order to reflect the observed vitamin A balances (net storage for control rats or net mobilization for TCDD-treated rats) (Fig. 5) . That is, we assumed a vitamin A steady state in all compartments except the most slowly turning-over storage compartments (compartment 4 in experiment 1 and compartment 3 in experiment 2). This analysis indicates that, although control and TCDD-treated rats consumed the same diet, TCDD-treated animals absorbed ~40 nmol/day less vitamin A than controls. TCDD exposure is frequently associated with a decrease in food intake (Pohjanvirta and Tuomisto, 1994) and in fact, our data on differences in body weight gain between TCDD-treated and control rats ( Table 1 ) may indicate that there was a decrease in food intake. Our calculations suggest that a small decrease in food intake, coupled with a decrease in vitamin A absorption efficiency, results in a vitamin A input into the system which is 40-50% lower in TCDD-treated than control rats. In other work in this lab, vitamin A absorption tended to be lower in lymph duct-cannulated rats given a single oral dose of TCDD (Hanberg et al., submitted for publication) . In spite of an estimated decrease in vitamin A absorption, we would have predicted, based on estimates (Green et al., 1985 (Green et al., , 1987 of vitamin A utilization in normal adult rats, that TCDDtreated rats in experiment 1 should have been in vitamin A balance and those in experiment 2 in positive balance. Since, in contrast, the data indicate that TCDD-treated rats in both experiments were in negative vitamin A balance, we conclude that TCDD affects vitamin A utilization (24-52% higher in TCDD-treated rats) independently of its effects on food intake and vitamin A absorption efficiency.
The rate of movement of vitamin A into slow turning-over storage compartments (compartment 4 in experiment 1 and compartment 3 in experiment 2) was not dramatically affected by TCDD treatment, especially in view of the predicted differences in vitamin A input. However, mobilization from those pools was high, resulting in a negative vitamin A balance in the liver of TCDD-treated rats. As argued above, TCDD may divert vitamin A into catabolic processes. Perhaps this diversion decreases the availability of retinol in a pool that is involved in the homeostatic regulation of retinyl ester hydrolysis. Since dietary supplementation with retinoic acid (Keilson et al., 1979) (and perhaps consequently cellular concentrations of retinoic acid) and the ratio of apo/holo cellular retinolbinding protein (CRBP) (Herr and Ong, 1992) have been shown to influence the mobilization of vitamin A from storage pools and the formation of retinyl esters, it would be interesting to study effects of TCDD on cellular retinoic acid, apo/holo CRBP ratios, and CRBP levels.
In conclusion, this paper presents the first application of model-based compartmental analysis to exploring the disruption of vitamin A homeostasis by TCDD. Our results indicate that the primary sites of the dysregulation by TCDD are increased catabolism and mobilization of vitamin A from slowly turning-over tissue stores of vitamin A (presumably mainly the liver). Based on our data, we are not able to say whether the increased utilization results in increased mobilization or whether the increased mobilization leads to increased utilization. Since past work and the current results suggest that the liver is a main target for TCDD's effects on vitamin A metabolism, it would be informative to characterize in detail the effects of TCDD on vitamin A dynamics in the liver, using an approach similar to that described by Green et al. (1993) . It would also be interesting to use kinetic approaches to study TCDD-related changes in renal vitamin A dynamics, in order to determine whether the reciprocal effects of TCDD on liver and kidney might be due to an alteration in signaling among kidneys, plasma, and liver.
